Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
Provided By GlobeNewswire
Last update: Sep 22, 2025
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025
Enrollment of the First Subject into Cohort 2 of the BB-301 Phase 1b/2a Treatment Study Expected in Q4 2025
Read more at globenewswire.com12.89
+0.1 (+0.78%)
Find more stocks in the Stock Screener
BNTC Latest News and Analysis
